ID   SSRA_HUMAN              Reviewed;         286 AA.
AC   P43307; A8K685; Q53GX2; Q53H19; Q5TAM3; Q6IB43; Q8NBH9; Q96IA2; Q9TNQ8;
AC   Q9UN49;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-2002, sequence version 3.
DT   18-JUN-2025, entry version 206.
DE   RecName: Full=Translocon-associated protein subunit alpha;
DE            Short=TRAP-alpha;
DE   AltName: Full=Signal sequence receptor subunit alpha;
DE            Short=SSR-alpha;
DE   Flags: Precursor;
GN   Name=SSR1; Synonyms=TRAPA; ORFNames=PSEC0262;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-28.
RX   PubMed=8050590; DOI=10.1016/0014-5793(94)00693-8;
RA   Hartmann E., Prehn S.;
RT   "The N-terminal region of the alpha-subunit of the TRAP complex has a
RT   conserved cluster of negative charges.";
RL   FEBS Lett. 349:324-326(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10437777; DOI=10.1016/s0014-5793(99)00885-6;
RA   Hirama T., Miller C.W., Koeffler H.P.;
RT   "Translocon-associated protein alpha transcripts are induced by
RT   granulocyte-macrophage colony-stimulating factor and exhibit complex
RT   alternative polyadenylation.";
RL   FEBS Lett. 455:223-227(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT SER-28.
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 19-31.
RX   PubMed=1557127; DOI=10.1038/356443a0;
RA   Wei M.L., Cresswell P.;
RT   "HLA-A2 molecules in an antigen-processing mutant cell contain signal
RT   sequence-derived peptides.";
RL   Nature 356:443-446(1992).
RN   [11]
RP   GLYCOSYLATION AT ASN-136.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247 AND SER-268, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-136 AND ASN-191.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-260 AND SER-268, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   INTERACTION WITH CALNEXIN.
RX   PubMed=22314232; DOI=10.1038/emboj.2012.15;
RA   Lakkaraju A.K., Abrami L., Lemmin T., Blaskovic S., Kunz B., Kihara A.,
RA   Dal Peraro M., van der Goot F.G.;
RT   "Palmitoylated calnexin is a key component of the ribosome-translocon
RT   complex.";
RL   EMBO J. 31:1823-1835(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24] {ECO:0007744|PDB:8B6L}
RP   STRUCTURE BY ELECTRON MICROSCOPY (7.60 ANGSTROMS) OF THE STT3A-CONTAINING
RP   OLIGOSACCHARYLTRANSFERASE (OST) AND TRANSLOCON COMPLEXES, AND SUBUNIT.
RX   PubMed=36697828; DOI=10.1038/s41586-022-05638-5;
RA   Gemmer M., Chaillet M.L., van Loenhout J., Cuevas Arenas R., Vismpas D.,
RA   Grollers-Mulderij M., Koh F.A., Albanese P., Scheltema R.A., Howes S.C.,
RA   Kotecha A., Fedry J., Forster F.;
RT   "Visualization of translation and protein biogenesis at the ER membrane.";
RL   Nature 614:160-167(2023).
CC   -!- FUNCTION: TRAP proteins are part of a complex whose function is to bind
CC       calcium to the ER membrane and thereby regulate the retention of ER
CC       resident proteins. May be involved in the recycling of the
CC       translocation apparatus after completion of the translocation process
CC       or may function as a membrane-bound chaperone facilitating folding of
CC       translocated proteins.
CC   -!- SUBUNIT: Heterotetramer of TRAP-alpha, TRAP-beta, TRAP-delta and TRAP-
CC       gamma (PubMed:36697828). Interacts with palmitoylated calnexin (CALX),
CC       the interaction is required for efficient folding of glycosylated
CC       proteins (PubMed:22314232). {ECO:0000269|PubMed:22314232,
CC       ECO:0000269|PubMed:36697828}.
CC   -!- INTERACTION:
CC       P43307; P27824: CANX; NbExp=7; IntAct=EBI-714168, EBI-355947;
CC       P43307; P60468: SEC61B; NbExp=2; IntAct=EBI-714168, EBI-1788819;
CC       P43307; P01009: SERPINA1; NbExp=4; IntAct=EBI-714168, EBI-986224;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass type
CC       I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P43307-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P43307-2; Sequence=VSP_013621;
CC   -!- DOMAIN: Shows a remarkable charge distribution with the N-terminus
CC       being highly negatively charged, and the cytoplasmic C-terminus
CC       positively charged.
CC   -!- MISCELLANEOUS: Seems to bind calcium.
CC   -!- SIMILARITY: Belongs to the TRAP-alpha family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z12830; CAA78290.1; -; mRNA.
DR   EMBL; AF156965; AAD48778.1; -; mRNA.
DR   EMBL; BT007387; AAP36051.1; -; mRNA.
DR   EMBL; AK291550; BAF84239.1; -; mRNA.
DR   EMBL; CR456961; CAG33242.1; -; mRNA.
DR   EMBL; AK222762; BAD96482.1; -; mRNA.
DR   EMBL; AK222809; BAD96529.1; -; mRNA.
DR   EMBL; AK075562; BAC11701.1; -; mRNA.
DR   EMBL; AL139095; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007710; AAH07710.1; -; mRNA.
DR   CCDS; CCDS4499.1; -. [P43307-1]
DR   PIR; I38246; I38246.
DR   RefSeq; NP_001278937.1; NM_001292008.1.
DR   RefSeq; NP_003135.2; NM_003144.5. [P43307-1]
DR   PDB; 8B6L; EM; 7.60 A; E=1-286.
DR   PDBsum; 8B6L; -.
DR   AlphaFoldDB; P43307; -.
DR   EMDB; EMD-15870; -.
DR   SMR; P43307; -.
DR   BioGRID; 112623; 464.
DR   ComplexPortal; CPX-8024; Translocon-associated protein complex.
DR   FunCoup; P43307; 2831.
DR   IntAct; P43307; 106.
DR   MINT; P43307; -.
DR   STRING; 9606.ENSP00000244763; -.
DR   TCDB; 3.A.5.9.1; the general secretory pathway (sec) family.
DR   GlyConnect; 1839; 29 N-Linked glycans (2 sites).
DR   GlyCosmos; P43307; 2 sites, 32 glycans.
DR   GlyGen; P43307; 8 sites, 53 N-linked glycans (2 sites), 1 O-linked glycan (2 sites).
DR   iPTMnet; P43307; -.
DR   MetOSite; P43307; -.
DR   PhosphoSitePlus; P43307; -.
DR   BioMuta; SSR1; -.
DR   DMDM; 22261821; -.
DR   CPTAC; CPTAC-593; -.
DR   CPTAC; CPTAC-594; -.
DR   jPOST; P43307; -.
DR   MassIVE; P43307; -.
DR   PaxDb; 9606-ENSP00000244763; -.
DR   PeptideAtlas; P43307; -.
DR   ProteomicsDB; 55609; -. [P43307-1]
DR   ProteomicsDB; 55610; -. [P43307-2]
DR   Pumba; P43307; -.
DR   TopDownProteomics; P43307-1; -. [P43307-1]
DR   TopDownProteomics; P43307-2; -. [P43307-2]
DR   Antibodypedia; 2405; 270 antibodies from 30 providers.
DR   DNASU; 6745; -.
DR   Ensembl; ENST00000244763.9; ENSP00000244763.4; ENSG00000124783.14. [P43307-1]
DR   GeneID; 6745; -.
DR   KEGG; hsa:6745; -.
DR   MANE-Select; ENST00000244763.9; ENSP00000244763.4; NM_003144.5; NP_003135.2.
DR   UCSC; uc003mxf.6; human. [P43307-1]
DR   AGR; HGNC:11323; -.
DR   CTD; 6745; -.
DR   DisGeNET; 6745; -.
DR   GeneCards; SSR1; -.
DR   HGNC; HGNC:11323; SSR1.
DR   HPA; ENSG00000124783; Low tissue specificity.
DR   MIM; 600868; gene.
DR   OpenTargets; ENSG00000124783; -.
DR   VEuPathDB; HostDB:ENSG00000124783; -.
DR   eggNOG; KOG1631; Eukaryota.
DR   GeneTree; ENSGT00400000022103; -.
DR   HOGENOM; CLU_073618_0_0_1; -.
DR   InParanoid; P43307; -.
DR   OMA; TFPYSFT; -.
DR   OrthoDB; 1926781at2759; -.
DR   PAN-GO; P43307; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; P43307; -.
DR   PathwayCommons; P43307; -.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   SignaLink; P43307; -.
DR   BioGRID-ORCS; 6745; 34 hits in 1167 CRISPR screens.
DR   ChiTaRS; SSR1; human.
DR   GeneWiki; SSR1; -.
DR   GenomeRNAi; 6745; -.
DR   Pharos; P43307; Tbio.
DR   PRO; PR:P43307; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; P43307; protein.
DR   Bgee; ENSG00000124783; Expressed in corpus epididymis and 215 other cell types or tissues.
DR   ExpressionAtlas; P43307; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0006613; P:cotranslational protein targeting to membrane; TAS:ProtInc.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
DR   InterPro; IPR005595; TRAP_alpha.
DR   PANTHER; PTHR12924:SF0; TRANSLOCON-ASSOCIATED PROTEIN SUBUNIT ALPHA; 1.
DR   PANTHER; PTHR12924; TRANSLOCON-ASSOCIATED PROTEIN, ALPHA SUBUNIT; 1.
DR   Pfam; PF03896; TRAP_alpha; 1.
DR   neXtProt; NX_P43307; -.
DR   PharmGKB; PA36147; -.
DR   TreeFam; TF321074; -.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Direct protein sequencing;
KW   Endoplasmic reticulum; Glycoprotein; Membrane; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000269|PubMed:1557127"
FT   CHAIN           19..286
FT                   /note="Translocon-associated protein subunit alpha"
FT                   /id="PRO_0000033281"
FT   TOPO_DOM        19..207
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        208..228
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        229..286
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          39..83
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          261..286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        39..75
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        268..279
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         247
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         260
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         268
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   CARBOHYD        136
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        191
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   VAR_SEQ         68..94
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16303743"
FT                   /id="VSP_013621"
FT   VARIANT         28
FT                   /note="L -> S (in dbSNP:rs10004)"
FT                   /evidence="ECO:0000269|PubMed:8050590, ECO:0000269|Ref.6"
FT                   /id="VAR_022427"
FT   CONFLICT        6
FT                   /note="R -> G (in Ref. 7; BAC11701)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        37
FT                   /note="E -> A (in Ref. 6; BAD96529)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        130
FT                   /note="Y -> H (in Ref. 1; CAA78290)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        190
FT                   /note="F -> Y (in Ref. 4; BAF84239)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220
FT                   /note="L -> P (in Ref. 6; BAD96529)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        263
FT                   /note="Q -> R (in Ref. 4; BAF84239)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        286
FT                   /note="E -> D (in Ref. 5; CAG33242)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   286 AA;  32235 MW;  2C631DC0CC3EB489 CRC64;
     MRLLPRLLLL LLLVFPATVL FRGGPRGLLA VAQDLTEDEE TVEDSIIEDE DDEAEVEEDE
     PTDLVEDKEE EDVSGEPEAS PSADTTILFV KGEDFPANNI VKFLVGFTNK GTEDFIVESL
     DASFRYPQDY QFYIQNFTAL PLNTVVPPQR QATFEYSFIP AEPMGGRPFG LVINLNYKDL
     NGNVFQDAVF NQTVTVIERE DGLDGETIFM YMFLAGLGLL VIVGLHQLLE SRKRKRPIQK
     VEMGTSSQND VDMSWIPQET LNQINKASPR RLPRKRAQKR SVGSDE
//
